CRONOS GROUP INC (CRON.TO) Financials
CRON.TO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.5 billion | 58.3 million |
2023-09-30 | 1.6 billion | 41.2 million |
2023-06-30 | 1.5 billion | 37.9 million |
2023-03-31 | 1.6 billion | 44.9 million |
CRON.TO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 19.9 million | 2.6 million |
2023-09-30 | -690397 | 2.7 million |
2023-06-30 | -16.3 million | 3.1 million |
2023-03-31 | -65.6 million | 3.5 million |
CRON.TO Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -59.4 million |
2023-09-30 | -2.2 million |
2023-06-30 | -11.1 million |
2023-03-31 | -26.1 million |
CRON.TO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 3.4 million |
2023-09-30 | 1.1 billion | - | 3.7 million |
2023-06-30 | 1.1 billion | - | 4.3 million |
2023-03-31 | 1.1 billion | - | 4.8 million |
CRON.TO Shares Outstanding
CRON.TO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.4 million | 1.9 million | 24.0 million | - |
2023-09-30 | 2.2 million | 1.7 million | 29.4 million | - |
2023-06-30 | 653958 | 1.5 million | 27.9 million | - |
2023-03-31 | 1.1 million | 2.8 million | 20.2 million | 7.9 million |
CRON.TO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 31.7 million | 29.2 million |
2023-09-30 | 33.7 million | 28.3 million |
2023-06-30 | 25.2 million | 21.1 million |
2023-03-31 | 27.3 million | 24.0 million |
CRON.TO
Price: CA$3.64
52 week price:
Earnings Per Share: -0.24 CAD
P/E Ratio: -7.12
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 341800
Market Capitalization: 1.3 billion